Cannabinoid hyperemesis syndrome: implications for pregnancy

Braillon, Alain; Bewley, Susan

doi:10.1136/bmj.l5587

Cited by 3 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some use cannabis to manage nausea in pregnancy, albeit against medical advice, 31 while conversely chronic use of cannabis has been associated with hyperemesis syndrome. 32 Furthermore, there is a potential for medicinal cannabis to be used to treat menstrual disorders and menopausal symptoms, including hot flushes, anxiety and mood changes, insomnia, pain, reduced libido and fatigue, 33 but there is limited research exploring the impact of medicinal cannabis use during pregnancy. 34 Limitations in information available can affect the clinician's ability to make informed decisions to support care in this group.…”

Section: Legalisation or Decriminalisationmentioning

confidence: 99%

The ethics and management of cannabis use in pregnancy following decriminalisation and licensing for medical use: narrative review

Towobola

Nair

et al. 2021

BJPsych Bull

View full text Add to dashboard Cite

Aims and method As drug policies pertaining to cannabis use become more liberalised, the prevalence of cannabis use in pregnancy could increase. However, there is limited guidance available for clinicians. This paper presents a narrative review of literature published in the past 16 years (2006–2021) to (a) address the impact of legalisation and decriminalisation on the risks, ethics and support of women who use cannabis during pregnancy and (b) develop guidance for clinicians. Results Both national and international trends suggest increased use of cannabis over the past decade, while the risks of cannabis use for recreational or medicinal purposes in pregnancy remain unmitigated. Clinical implications This review confirmed that the recommendation of cannabinoid-based products for pregnant and breast-feeding women is currently premature. More research is needed to address safety concerns. We discussed navigating ethical concerns and suggest targeted management strategies for clinicians treating pregnant women who choose to use cannabis.

show abstract

Section: Legalisation or Decriminalisationmentioning

confidence: 99%

The ethics and management of cannabis use in pregnancy following decriminalisation and licensing for medical use: narrative review

Towobola

Nair

et al. 2021

BJPsych Bull

View full text Add to dashboard Cite

show abstract

“…Braillon and Bewley emphasise the importance of recognising cannabinoid hyperemesis syndrome; we are pleased that our article might help patients and physicians tackle this condition 12. Our aim was not to consider any issue related to legalisation or liberalisation of cannabis.…”

mentioning

confidence: 99%